PR208a : High-density prostate cancer tissue array, including TNM, pathology grade and Gleason score, 64 cases/192 cores, replacing PR208
|
Microarray Panel | High-density prostate adenocarcinoma tissue microarray, containing 58 cases of adenocarcinoma from grade 1-4, 6 normal prostate tissue, triplicate cores per case | |
Cores | 192 | |
Cases | 64 | |
Row number | 12 | |
Column number | 16 | |
Core Diameter (mm) | 1 | |
Thickness (µm) | 5 | |
Tissue Array Type | FFPE | |
Species | Human | |
Applications | Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page. | |
Notes | 1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours. In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers. |
Mouseover and click individual cores to view high resolution images.
Legend: | Pro - Prostate - Malignant tumor, - Normal tissue |
Specification Sheet (Sortable), tissue IDs are available in exported Excel files.
Pos. | No. | Age | Sex | Organ/Anatomic Site | Pathology diagnosis | TNM | Grade | Stage | Type | Gleason Score | Gleason Grade | Image |
---|
A1 | 1 | 68 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 2+3 | 1 | ||
A2 | 2 | 68 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 2+3 | 1 | ||
A3 | 3 | 68 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 2+3 | 1 | ||
A4 | 4 | 63 | M | Prostate | Adenocarcinoma | T3N0M0 | 1 | Malignant | 1+2 | 1 | ||
A5 | 5 | 63 | M | Prostate | Adenocarcinoma | T3N0M0 | 1 | Malignant | 1+2 | 1 | ||
A6 | 6 | 63 | M | Prostate | Adenocarcinoma | T3N0M0 | 1 | Malignant | 1+2 | 1 | ||
A7 | 7 | 74 | M | Prostate | Adenocarcinoma | T2N0M0 | 1 | Malignant | 1+2 | 1 | ||
A8 | 8 | 74 | M | Prostate | Adenocarcinoma | T2N0M0 | 1 | Malignant | 1+2 | 1 | ||
A9 | 9 | 74 | M | Prostate | Adenocarcinoma | T2N0M0 | 1 | Malignant | 1+2 | 1 | ||
A10 | 10 | 26 | M | Prostate | Adenocarcinoma(hyperplasia) | T2N0M0 | - | Malignant | - | |||
A11 | 11 | 26 | M | Prostate | Adenocarcinoma(hyperplasia) | T2N0M0 | - | Malignant | - | |||
A12 | 12 | 26 | M | Prostate | Adenocarcinoma(hyperplasia) | T2N0M0 | - | Malignant | - | |||
A13 | 13 | 66 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 2+2 | 1 | ||
A14 | 14 | 66 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 2+2 | 1 | ||
A15 | 15 | 66 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 2+2 | 1 | ||
A16 | 16 | 66 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 1+2 | 1 | ||
B1 | 17 | 66 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 1+2 | 1 | ||
B2 | 18 | 66 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 1+2 | 1 | ||
B3 | 19 | 57 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 2+3 | 1 | ||
B4 | 20 | 57 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 2+3 | 1 | ||
B5 | 21 | 57 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 2+3 | 1 | ||
B6 | 22 | 71 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 2+2 | 1 | ||
B7 | 23 | 71 | M | Prostate | Adenocarcinoma(smooth muscle) | T2N0M0 | - | Malignant | - | |||
B8 | 24 | 71 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 2+2 | 1 | ||
B9 | 25 | 75 | M | Prostate | Adenocarcinoma | T2N0M0 | 1--2 | Malignant | 2+2 | 1 | ||
B10 | 26 | 75 | M | Prostate | Adenocarcinoma | T2N0M0 | 1--2 | Malignant | 2+2 | 1 | ||
B11 | 27 | 75 | M | Prostate | Adenocarcinoma | T2N0M0 | 1--2 | Malignant | 2+2 | 1 | ||
B12 | 28 | 72 | M | Prostate | Adenocarcinoma | T2N0M0 | 1--2 | Malignant | 3+4 | 2 | ||
B13 | 29 | 72 | M | Prostate | Adenocarcinoma | T2N0M0 | 1--2 | Malignant | 3+4 | 2 | ||
B14 | 30 | 72 | M | Prostate | Adenocarcinoma | T2N0M0 | 1--2 | Malignant | 3+4 | 2 | ||
B15 | 31 | 73 | M | Prostate | Adenocarcinoma | T2N0M0 | 1--2 | Malignant | 3+3 | 1 | ||
B16 | 32 | 73 | M | Prostate | Adenocarcinoma | T2N0M0 | 1--2 | Malignant | 3+3 | 1 | ||
C1 | 33 | 73 | M | Prostate | Adenocarcinoma | T2N0M0 | 1--2 | Malignant | 3+3 | 1 | ||
C2 | 34 | 67 | M | Prostate | Adenocarcinoma | T2N0M1 | 1--2 | Malignant | 3+3 | 1 | ||
C3 | 35 | 67 | M | Prostate | Adenocarcinoma | T2N0M1 | 1--2 | Malignant | 3+3 | 1 | ||
C4 | 36 | 67 | M | Prostate | Adenocarcinoma | T2N0M1 | 1--2 | Malignant | 3+3 | 1 | ||
C5 | 37 | 65 | M | Prostate | Adenocarcinoma | T2N0M0 | 1--2 | Malignant | 2+3 | 1 | ||
C6 | 38 | 65 | M | Prostate | Adenocarcinoma | T2N0M0 | 1--2 | Malignant | 2+3 | 1 | ||
C7 | 39 | 65 | M | Prostate | Adenocarcinoma | T2N0M0 | 1--2 | Malignant | 2+3 | 1 | ||
C8 | 40 | 65 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+3 | 1 | ||
C9 | 41 | 65 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+3 | 1 | ||
C10 | 42 | 65 | M | Prostate | Adenocarcinoma | T2N0M0 | 2--3 | Malignant | 3+3 | 1 | ||
C11 | 43 | 83 | M | Prostate | Adenocarcinoma(hyperplasia) | T2N0M0 | - | Malignant | - | |||
C12 | 44 | 83 | M | Prostate | Adenocarcinoma(hyperplasia) | T2N0M0 | - | Malignant | - | |||
C13 | 45 | 83 | M | Prostate | Adenocarcinoma(hyperplasia) | T2N0M0 | - | Malignant | - | |||
C14 | 46 | 70 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+4 | 2 | ||
C15 | 47 | 70 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+4 | 2 | ||
C16 | 48 | 70 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+4 | 2 | ||
D1 | 49 | 56 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+4 | 2 | ||
D2 | 50 | 56 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+4 | 2 | ||
D3 | 51 | 56 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+4 | 2 | ||
D4 | 52 | 75 | M | Prostate | Adenocarcinoma | T2aN0M0 | 2 | Malignant | 2+4 | 1 | ||
D5 | 53 | 75 | M | Prostate | Adenocarcinoma | T2aN0M0 | 2 | Malignant | 2+4 | 1 | ||
D6 | 54 | 75 | M | Prostate | Adenocarcinoma | T2aN0M0 | 2 | Malignant | 2+4 | 1 | ||
D7 | 55 | 64 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+3 | 1 | ||
D8 | 56 | 64 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+3 | 1 | ||
D9 | 57 | 64 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+3 | 1 | ||
D10 | 58 | 71 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+4 | 2 | ||
D11 | 59 | 71 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+4 | 2 | ||
D12 | 60 | 71 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+4 | 2 | ||
D13 | 61 | 82 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+4 | 2 | ||
D14 | 62 | 82 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+4 | 2 | ||
D15 | 63 | 82 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+4 | 2 | ||
D16 | 64 | 73 | M | Prostate | Adenocarcinoma | T3N0M0 | 2 | Malignant | 3+3 | 1 | ||
E1 | 65 | 73 | M | Prostate | Adenocarcinoma | T3N0M0 | 2 | Malignant | 3+3 | 1 | ||
E2 | 66 | 73 | M | Prostate | Adenocarcinoma | T3N0M0 | 2 | Malignant | 3+3 | 1 | ||
E3 | 67 | 60 | M | Prostate | Adenocarcinoma | T3N1M0 | 2 | Malignant | 3+4 | 2 | ||
E4 | 68 | 60 | M | Prostate | Adenocarcinoma | T3N1M0 | 2 | Malignant | 3+4 | 2 | ||
E5 | 69 | 60 | M | Prostate | Adenocarcinoma | T3N1M0 | 2 | Malignant | 3+4 | 2 | ||
E6 | 70 | 64 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+4 | 2 | ||
E7 | 71 | 64 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+4 | 2 | ||
E8 | 72 | 64 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+4 | 2 | ||
E9 | 73 | 69 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+3 | 1 | ||
E10 | 74 | 69 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+3 | 1 | ||
E11 | 75 | 69 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+3 | 1 | ||
E12 | 76 | 62 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+4 | 2 | ||
E13 | 77 | 62 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+4 | 2 | ||
E14 | 78 | 62 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+4 | 2 | ||
E15 | 79 | 73 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+4 | 2 | ||
E16 | 80 | 73 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+4 | 2 | ||
F1 | 81 | 73 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+4 | 2 | ||
F2 | 82 | 61 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+4 | 2 | ||
F3 | 83 | 61 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+4 | 2 | ||
F4 | 84 | 61 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+4 | 2 | ||
F5 | 85 | 70 | M | Prostate | Adenocarcinoma | T3N0M0 | 2 | Malignant | 3+4 | 2 | ||
F6 | 86 | 70 | M | Prostate | Adenocarcinoma | T3N0M0 | 2 | Malignant | 3+4 | 2 | ||
F7 | 87 | 70 | M | Prostate | Adenocarcinoma | T3N0M0 | 2 | Malignant | 3+4 | 2 | ||
F8 | 88 | 73 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+4 | 2 | ||
F9 | 89 | 73 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+4 | 2 | ||
F10 | 90 | 73 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+4 | 2 | ||
F11 | 91 | 76 | M | Prostate | Adenocarcinoma | T2AN0M0 | 2 | Malignant | 3+3 | 1 | ||
F12 | 92 | 76 | M | Prostate | Adenocarcinoma | T2AN0M0 | 2 | Malignant | 3+3 | 1 | ||
F13 | 93 | 76 | M | Prostate | Adenocarcinoma | T2AN0M0 | 2 | Malignant | 3+3 | 1 | ||
F14 | 94 | 69 | M | Prostate | Adenocarcinoma | T3N0M0 | 2 | Malignant | 3+3 | 1 | ||
F15 | 95 | 69 | M | Prostate | Adenocarcinoma (sparse) | T3N0M0 | - | Malignant | - | |||
F16 | 96 | 69 | M | Prostate | Adenocarcinoma | T3N0M0 | 2 | Malignant | 3+3 | 1 | ||
G1 | 97 | 65 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+5 | 4 | ||
G2 | 98 | 65 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+5 | 4 | ||
G3 | 99 | 65 | M | Prostate | Adenocarcinoma | T2N0M0 | 2 | Malignant | 3+5 | 4 | ||
G4 | 100 | - | M | Prostate | Adenocarcinoma(hyperplasia) | T2AN0M0 | - | Malignant | - | |||
G5 | 101 | - | M | Prostate | Adenocarcinoma(smooth muscle) | T2AN0M0 | - | Malignant | - | |||
G6 | 102 | - | M | Prostate | Adenocarcinoma(smooth muscle) | T2AN0M0 | - | Malignant | - | |||
G7 | 103 | 62 | M | Prostate | Adenocarcinoma | T3N0M0 | 2--3 | Malignant | 3+4 | 2 | ||
G8 | 104 | 62 | M | Prostate | Adenocarcinoma | T3N0M0 | 2--3 | Malignant | 3+4 | 2 | ||
G9 | 105 | 62 | M | Prostate | Adenocarcinoma | T3N0M0 | 2--3 | Malignant | 3+4 | 2 | ||
G10 | 106 | 76 | M | Prostate | Adenocarcinoma | T3N0M0 | 2--3 | Malignant | 4+5 | 5 | ||
G11 | 107 | 76 | M | Prostate | Adenocarcinoma | T3N0M0 | 2--3 | Malignant | 4+5 | 5 | ||
G12 | 108 | 76 | M | Prostate | Adenocarcinoma | T3N0M0 | 2--3 | Malignant | 4+5 | 5 | ||
G13 | 109 | 82 | M | Prostate | Adenocarcinoma | T3N0M0 | 2--3 | Malignant | 3+4 | 2 | ||
G14 | 110 | 82 | M | Prostate | Adenocarcinoma | T3N0M0 | 2--3 | Malignant | 3+4 | 2 | ||
G15 | 111 | 82 | M | Prostate | Adenocarcinoma | T3N0M0 | 2--3 | Malignant | 3+4 | 2 | ||
G16 | 112 | 64 | M | Prostate | Adenocarcinoma | T3N0M0 | 2--3 | Malignant | 4+5 | 5 | ||
H1 | 113 | 64 | M | Prostate | Adenocarcinoma | T3N0M0 | 2--3 | Malignant | 4+5 | 5 | ||
H2 | 114 | 64 | M | Prostate | Adenocarcinoma | T3N0M0 | 2--3 | Malignant | 4+5 | 5 | ||
H3 | 115 | 64 | M | Prostate | Adenocarcinoma | T3N0M0 | 2 | Malignant | 3+3 | 1 | ||
H4 | 116 | 64 | M | Prostate | Adenocarcinoma | T3N0M0 | 2 | Malignant | 3+3 | 1 | ||
H5 | 117 | 64 | M | Prostate | Adenocarcinoma | T3N0M0 | 2 | Malignant | 3+3 | 1 | ||
H6 | 118 | 78 | M | Prostate | Adenocarcinoma | T2N0M0 | 2--3 | Malignant | 4+5 | 5 | ||
H7 | 119 | 78 | M | Prostate | Adenocarcinoma | T2N0M0 | 2--3 | Malignant | 4+5 | 5 | ||
H8 | 120 | 78 | M | Prostate | Adenocarcinoma | T2N0M0 | 2--3 | Malignant | 4+5 | 5 | ||
H9 | 121 | 64 | M | Prostate | Adenocarcinoma | T2N0M0 | 2--3 | Malignant | 3+5 | 4 | ||
H10 | 122 | 64 | M | Prostate | Adenocarcinoma | T2N0M0 | 2--3 | Malignant | 3+5 | 4 | ||
H11 | 123 | 64 | M | Prostate | Adenocarcinoma | T2N0M0 | 2--3 | Malignant | 3+5 | 4 | ||
H12 | 124 | 66 | M | Prostate | Adenocarcinoma | T3AN0M0 | 2--3 | Malignant | 3+5 | 4 | ||
H13 | 125 | 66 | M | Prostate | Adenocarcinoma | T3AN0M0 | 2--3 | Malignant | 3+5 | 4 | ||
H14 | 126 | 66 | M | Prostate | Adenocarcinoma | T3AN0M0 | 2--3 | Malignant | 3+5 | 4 | ||
H15 | 127 | 64 | M | Prostate | Adenocarcinoma | T2AN0M0 | 2--3 | Malignant | 3+4 | 2 | ||
H16 | 128 | 64 | M | Prostate | Adenocarcinoma | T2AN0M0 | 2--3 | Malignant | 3+4 | 2 | ||
I1 | 129 | 64 | M | Prostate | Adenocarcinoma | T2AN0M0 | 2--3 | Malignant | 3+4 | 2 | ||
I2 | 130 | 73 | M | Prostate | Adenocarcinoma(Fibrovascular) | T4N0M0 | - | Malignant | - | |||
I3 | 131 | 73 | M | Prostate | Adenocarcinoma | T4N0M0 | 3 | Malignant | 5+5 | 5 | ||
I4 | 132 | 73 | M | Prostate | Adenocarcinoma | T4N0M0 | 3 | Malignant | 5+5 | 5 | ||
I5 | 133 | 63 | M | Prostate | Adenocarcinoma | T2N0M0 | 3 | Malignant | 4+5 | 5 | ||
I6 | 134 | 63 | M | Prostate | Adenocarcinoma | T2N0M0 | 3 | Malignant | 4+5 | 5 | ||
I7 | 135 | 63 | M | Prostate | Adenocarcinoma | T2N0M0 | 3 | Malignant | 4+5 | 5 | ||
I8 | 136 | 60 | M | Prostate | Adenocarcinoma | T2N0M0 | 3 | Malignant | 5+5 | 5 | ||
I9 | 137 | 60 | M | Prostate | Adenocarcinoma | T2N0M0 | 3 | Malignant | 5+5 | 5 | ||
I10 | 138 | 60 | M | Prostate | Adenocarcinoma | T2N0M0 | 3 | Malignant | 5+5 | 5 | ||
I11 | 139 | 80 | M | Prostate | Adenocarcinoma | T2N0M0 | 3 | Malignant | 4+5 | 5 | ||
I12 | 140 | 80 | M | Prostate | Adenocarcinoma | T2N0M0 | 3 | Malignant | 4+5 | 5 | ||
I13 | 141 | 80 | M | Prostate | Adenocarcinoma | T2N0M0 | 3 | Malignant | 4+5 | 5 | ||
I14 | 142 | 73 | M | Prostate | Adenocarcinoma | T2BN0M0 | 3 | Malignant | 5+4 | 5 | ||
I15 | 143 | 73 | M | Prostate | Adenocarcinoma | T2BN0M0 | 3 | Malignant | 5+4 | 5 | ||
I16 | 144 | 73 | M | Prostate | Adenocarcinoma | T2BN0M0 | 3 | Malignant | 5+4 | 5 | ||
J1 | 145 | 64 | M | Prostate | Adenocarcinoma | T2N0M0 | 2--3 | Malignant | 3+4 | 2 | ||
J2 | 146 | 64 | M | Prostate | Adenocarcinoma | T2N0M0 | - | Malignant | - | |||
J3 | 147 | 64 | M | Prostate | Adenocarcinoma | T2N0M0 | 2--3 | Malignant | 3+4 | 2 | ||
J4 | 148 | 68 | M | Prostate | Adenocarcinoma(blank) | T2N0M0 | - | Malignant | - | |||
J5 | 149 | 68 | M | Prostate | Adenocarcinoma(Fibrovascular) | T2N0M0 | - | Malignant | - | |||
J6 | 150 | 68 | M | Prostate | Adenocarcinoma | T2N0M0 | 3 | Malignant | 5+5 | 5 | ||
J7 | 151 | 87 | M | Prostate | Adenocarcinoma | T2N0M0 | 3 | Malignant | 5+4 | 5 | ||
J8 | 152 | 87 | M | Prostate | Adenocarcinoma | T2N0M0 | 3 | Malignant | 5+4 | 5 | ||
J9 | 153 | 87 | M | Prostate | Adenocarcinoma | T2N0M0 | 3 | Malignant | 5+4 | 5 | ||
J10 | 154 | 72 | M | Prostate | Adenocarcinoma | T3N0M0 | 3 | Malignant | 5+4 | 5 | ||
J11 | 155 | 72 | M | Prostate | Adenocarcinoma(Fibrovascular) | T3N0M0 | - | Malignant | - | |||
J12 | 156 | 72 | M | Prostate | Adenocarcinoma(Fibrovascular) | T3N0M0 | - | Malignant | - | |||
J13 | 157 | 82 | M | Prostate | Adenocarcinoma | T2N0M0 | 3 | Malignant | 5+4 | 5 | ||
J14 | 158 | 82 | M | Prostate | Adenocarcinoma | T2N0M0 | 3 | Malignant | 5+4 | 5 | ||
J15 | 159 | 82 | M | Prostate | Adenocarcinoma | T2N0M0 | 3 | Malignant | 5+4 | 5 | ||
J16 | 160 | 62 | M | Prostate | Adenocarcinoma | T2N0M0 | 3 | Malignant | 4+5 | 5 | ||
K1 | 161 | 62 | M | Prostate | Adenocarcinoma | T2N0M0 | 3 | Malignant | 4+5 | 5 | ||
K2 | 162 | 62 | M | Prostate | Adenocarcinoma | T2N0M0 | 3 | Malignant | 4+5 | 5 | ||
K3 | 163 | 77 | M | Prostate | Adenocarcinoma | T2N0M0 | 3 | Malignant | 5+5 | 5 | ||
K4 | 164 | 77 | M | Prostate | Adenocarcinoma | T2N0M0 | 3 | Malignant | 5+5 | 5 | ||
K5 | 165 | 77 | M | Prostate | Adenocarcinoma | T2N0M0 | 3 | Malignant | 5+5 | 5 | ||
K6 | 166 | 60 | M | Prostate | Adenocarcinoma | T2N0M0 | 3 | Malignant | 5+5 | 5 | ||
K7 | 167 | 60 | M | Prostate | Adenocarcinoma | T2N0M0 | 3 | Malignant | 5+5 | 5 | ||
K8 | 168 | 60 | M | Prostate | Adenocarcinoma | T2N0M0 | 3 | Malignant | 5+5 | 5 | ||
K9 | 169 | 81 | M | Prostate | Adenocarcinoma | T3AN0M0 | 3 | Malignant | 5+4 | 5 | ||
K10 | 170 | 81 | M | Prostate | Adenocarcinoma | T3AN0M0 | 3 | Malignant | 5+4 | 5 | ||
K11 | 171 | 81 | M | Prostate | Adenocarcinoma | T3AN0M0 | 3 | Malignant | 5+4 | 5 | ||
K12 | 172 | 70 | M | Prostate | Small acinar cancer | T2N0M0 | - | Malignant | - | |||
K13 | 173 | 70 | M | Prostate | Small acinar cancer | T2N0M0 | - | Malignant | - | |||
K14 | 174 | 70 | M | Prostate | Small acinar cancer | T2N0M0 | - | Malignant | - | |||
K15 | 175 | 45 | M | Prostate | Prostate tissue | - | - | Normal | - | |||
K16 | 176 | 45 | M | Prostate | Prostate tissue | - | - | Normal | - | |||
L1 | 177 | 45 | M | Prostate | Prostate tissue | - | - | Normal | - | |||
L2 | 178 | 40 | M | Prostate | Prostate tissue | - | - | Normal | - | |||
L3 | 179 | 40 | M | Prostate | Prostate tissue | - | - | Normal | - | |||
L4 | 180 | 40 | M | Prostate | Prostate tissue | - | - | Normal | - | |||
L5 | 181 | 30 | M | Prostate | Prostate tissue | - | - | Normal | - | |||
L6 | 182 | 30 | M | Prostate | Prostate tissue | - | - | Normal | - | |||
L7 | 183 | 30 | M | Prostate | Prostate tissue | - | - | Normal | - | |||
L8 | 184 | 32 | M | Prostate | Prostate tissue | - | - | Normal | - | |||
L9 | 185 | 32 | M | Prostate | Prostate tissue | - | - | Normal | - | |||
L10 | 186 | 32 | M | Prostate | Prostate tissue | - | - | Normal | - | |||
L11 | 187 | 30 | M | Prostate | Prostate tissue | - | - | Normal | - | |||
L12 | 188 | 30 | M | Prostate | Prostate tissue | - | - | Normal | - | |||
L13 | 189 | 30 | M | Prostate | Prostate tissue | - | - | Normal | - | |||
L14 | 190 | 35 | M | Prostate | Prostate tissue | - | - | Normal | - | |||
L15 | 191 | 35 | M | Prostate | Prostate tissue | - | - | Normal | - | |||
L16 | 192 | 35 | M | Prostate | Prostate tissue | - | - | Normal | - | |||
- | 0 | 42 | M | Adrenal gland | Pheochromocytoma (tissue marker) | - | Malignant |
Find overlapping cases with this tissue array:
- Product Code: PR208a
- Availability: In Stock